Laboratorios Lesvi S.L. neuraxpharm Arzneimittel GmbH

Poland

All drugs from this manufacturer

  • MEMANTIN NEUROPHARMA

    The medicine is intended for the treatment of patients with moderate to severe Alzheimer's disease.

    Dosage form: tablets, film-coated

    Active substance Dosage
    memantine hydrochloride 20 mg

    ATC: N06DX01

  • The medicine is used for the treatment of patients with moderate to severe Alzheimer's disease.

    Dosage form: tablets, film-coated

    Active substance Dosage
    memantine hydrochloride 10 mg

    ATC: N06DX01